Developing Novel Diagnostic Tests to Improve Surveillance for Antimicrobial Resistant Pathogens (U01)

Post Date

March 19th 2010

Application Due Date

April 19th 2010

Funding Opportunity Number

RFA-CI-10-002

CFDA Number(s)

93.283

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $900000

• Award Range:

  $0 - $0

Grant Description

CDC’s Procurement and Grants Office has published a funding opportunity announcement entitled, “Developing Novel Diagnostic Tests to Improve Surveillance for Antimicrobial Resistant Pathogens (U01)”. Approximately $300,000 will be available in fiscal year 2010 to fund one award. The purpose of this U01 is to develop novel diagnostic tests in concert with current antimicrobial surveillance efforts to improve local or regional surveillance for antimicrobial resistant pathogens. The tests could also be used to identify patients colonized or infected with transmissible antimicrobial resistant pathogens for implementation of infection control precautions.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Center for Disease Control and Prevention (CDC)
  Procurement and Grants Office (PGO)
  Technical and Information Management Section (TIMS)
  Phone 770-488-2700

• Agency Mailing Address:

  General Email

• Agency Email Address:

  pgotim@cdc.gov

• Location:

  Centers for Disease Control and Prevention

• More Information:

  Please click on the full announcement box at the top of this page